SXM CEO, Dr Sophia E. Shanko, invited to speak at the Stakeholder Meeting on “Innovative Antimicrobial Therapy Development” from the Center for Future Affordable Sustainable Therapy Development (FAST) in collaboration with the Dutch Ministry of Health, The Dutch Research Council NWO, The Netherlands Organization for Health Research and Development (ZonMw), and the Netherlands Enterprise Agency RVO.
